Login / Signup

Quantitative proteomics in medication-related osteonecrosis of the jaw: A proof-of-concept study.

Alejandro Ismael Lorenzo-PousoSusana B BravoJavier CarballoMaría Del Pilar Chantada-VázquezJosé BagánLeticia BagánCintia Micaela Chamorro-PetronacciMercedes Conde-AmboageRafael López-LópezAbel García-GarcíaMário Pérez-Sayáns
Published in: Oral diseases (2022)
These findings may inform a novel biomarker panel for MRONJ prediction or diagnosis. Nonetheless, further research is needed to validate this panel.
Keyphrases
  • mass spectrometry
  • healthcare
  • high resolution
  • adverse drug